Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 11/20 | 0.44 |
| ▸ | CTSS | P25774 | 7/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 2/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1338105 | 1.00 | CTSK (0.44) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2446579 | 1.00 | CTSK (0.44) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL29727325 | 0.92 | CTSK (0.50) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL30788958 | 0.92 | CTSK (0.46) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL4702036 | 0.87 | CYP1A2 (0.58) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL1519852 | 0.86 | CYP1A2 (0.46) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL1712024 | 0.86 | CYP1A2 (0.46) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL1743738 | 0.86 | CYP1A2 (0.46) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL24299005 | 0.85 | CTSK (0.46) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL22035781 | 0.85 | CTSK (0.46) | CTSKCTSSCYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118858486-A | Chiral detection method of (2R) -2- [ [ tert-butoxycarbonyl ] amino ] -4-iodobutyric acid methyl ester | 上海吉奉生物科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118858486-A | Chiral detection method of (2R) -2- [ [ tert-butoxycarbonyl ] amino ] -4-iodobutyric acid methyl ester | 上海吉奉生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118858486-A | Chiral detection method of (2R) -2- [ [ tert-butoxycarbonyl ] amino ] -4-iodobutyric acid methyl ester | 上海吉奉生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118858486-A | Chiral detection method of (2R) -2- [ [ tert-butoxycarbonyl ] amino ] -4-iodobutyric acid methyl ester | 上海吉奉生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-2524925-B1 | LANTHIONINE DERIVATIVE | AJINOMOTO KK (JP) | 2016-08-17 | — | — | EP | disclosed |
| US-8568814-B2 | Lanthionine derivatives | AJINOMOTO CO., INC. (JP) | 2013-10-29 | — | — | US | disclosed |
| US-8568814-B2 | Lanthionine derivatives | AJINOMOTO CO., INC. (JP) | 2013-10-29 | — | — | US | disclosed |
| US-20120282386-A1 | LANTHIONINE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120282386-A1 | LANTHIONINE DERIVATIVES | CASR, KCNJ5, CALCR | CTSK 693/4885CTSS 1628/4885CYP1A2 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.